Search
                    Critical Limb Ischemia Clinical Trials
A listing of 8  Critical Limb Ischemia  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 8 of 8
        
        
    
                There are currently 8 active clinical trials seeking participants for Critical Limb Ischemia research studies. The states with the highest number of trials for Critical Limb Ischemia participants are Florida, California, Texas and Massachusetts.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
                                
            
            
        Recruiting
                            
            
                This is a preliminary prospective observational study measuring change in lower extremity temperature in response to revascularization procedure.
The main question this study aims to answer is:
- Are temperature measurements from a forward looking infrared (FLIR) camera of the lower extremity useful in predicting outcome of revascularization procedures?             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 99 years
            Trial Updated:
                05/08/2025
            
            Locations: University Hospitals Ahuja Medical Center, Beachwood, Ohio  +2 locations         
        
        
            Conditions: Peripheral Arterial Disease, Critical Limb Ischemia, Critical Lower Limb Ischemia
        
            
        
    
                
                                    Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
                                
            
            
        Recruiting
                            
            
                A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of ischemia-driven major amputation, clinically driven target lesion revascularization, and clinically relevant target lesion occlusion after revascularization of lesions below the knee in patients with symptomatic Rutherford 3-5 peripheral artery disease. The primary safety endpoint will be gathered at 1-month post-index procedure. The primar...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/31/2025
            
            Locations: Cardiovascular Institute of the South, Houma, Louisiana  +1 locations         
        
        
            Conditions: Peripheral Artery Disease, Critical Limb Ischemia
        
            
        
    
                
                                    Nutrition in Patient With Critical Limb Ischemia
                                
            
            
        Recruiting
                            
            
                A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of malnutrition and has the potential to benefit greatly from nutritional intervention. The investigators plan to evaluate nutrition and functional status of patients by assessing objective lab values and the use of the hand grip strength test. Providing perioperative nutritional supplements to patients has potentially improved their nutriti...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 99 years
            Trial Updated:
                06/25/2025
            
            Locations: Boston Medical Center, Boston, Massachusetts         
        
        
            Conditions: Critical Limb Ischemia, Malnutrition, Nutritional Supplements
        
            
        
    
                
                                    Serrantor OCT Study
                                
            
            
        Recruiting
                            
            
                TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.             
        
        
    Gender:
                ALL
            Ages:
                19 years and above
            Trial Updated:
                05/14/2025
            
            Locations: Columbia University, New York, New York  +1 locations         
        
        
            Conditions: Critical Limb Ischemia
        
            
        
    
                
                                    MOTIV BTK Randomized Controlled Trial
                                
            
            
        Recruiting
                            
            
                Pre-market clinical evaluation of the MOTIV Sirolimus-Eluting Bioresorbable Scaffold for the planned treatment of infrapopliteal lesions.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                04/01/2025
            
            Locations: Adventist Health, Saint Helena, California  +3 locations         
        
        
            Conditions: Critical Limb Ischemia
        
            
        
    
                
                                    CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
                                
            
            
        Recruiting
                            
            
                The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/05/2025
            
            Locations: Yale New Haven Health, New Haven, Connecticut         
        
        
            Conditions: Femoral Arterial Calcification, Peripheral Arterial Disease, Claudication, Critical Limb Ischemia
        
            
        
    
                
                                    Trial to Assess Chelation Therapy in Critical Limb Ischemia
                                
            
            
        Recruiting
                            
            
                TACT3a is a double blind, placebo-controlled, randomized trial to test a novel therapy, edetate disodium-based chelation of environmentally acquired toxic metals, to reduce cardiovascular events including amputation in high-risk diabetic patients.             
        
        
    Gender:
                ALL
            Ages:
                50 years and above
            Trial Updated:
                08/20/2024
            
            Locations: Mount Sinai Medical Center, Miami Beach, Florida         
        
        
            Conditions: Critical Limb Ischemia, Diabetes
        
            
        
    
                
                                    PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
                                
            
            
        Recruiting
                            
            
                A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 95 years
            Trial Updated:
                05/31/2024
            
            Locations: University of California, San Diego Health, La Jolla, California  +29 locations         
        
        
            Conditions: Critical Limb Ischemia, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia
        
            
        
    1 - 8 of 8
            
            
        